Radiofrequency Ablation Clinical Trial
Official title:
The Short-term Efficacy of Novel No-touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma With Cirrhosis.
To evaluate the short-term efficacy of novel no-touch combined directional perfusion radiofrequency ablation in the treatment of small hepatocellular carcinoma with cirrhosis.
Liver cancer is the fourth leading cause of cancer-related deaths globally. Hepatocellular carcinoma (HCC) accounts for 70% to 85% of primary HCC and is the leading cause of death in patients with cirrhosis. We developed a novel no-touch combined directional perfusion radiofrequency ablation system.By inserting two or more electrodes around the tumor and activating them simultaneously.The hypertonic saline solution can be directed into the focal tissue from a lateral pore through a tube within the electrode to provide more uniform and thorough necrosis.The maximum ablation volume was increased while the loss of normal tissue in the non-injection direction was reduced, thus reducing the incidence of postoperative complications. Therefore, the purpose of this study was to evaluate the short-term efficacy of novel no-touch combined directional perfusion radiofrequency ablation in the treatment of small hepatocellular carcinoma with cirrhosis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04420013 -
Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon
|
||
Completed |
NCT02382289 -
Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points
|
N/A | |
Terminated |
NCT06371716 -
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions
|
N/A | |
Terminated |
NCT03247413 -
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
|
Phase 4 | |
Recruiting |
NCT06033456 -
Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome
|
N/A | |
Not yet recruiting |
NCT05559073 -
Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
|
||
Completed |
NCT05078541 -
Radiofrequency Ablation for Warthin's Tumor
|
N/A | |
Recruiting |
NCT06003218 -
Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation
|
N/A | |
Recruiting |
NCT05500703 -
Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia
|
Phase 4 | |
Completed |
NCT05719948 -
Combined Continuous and Pulsed Radiofrequency Ablation for Pain Relief and Their Safety in Cervical Facet Pain
|
N/A | |
Completed |
NCT03375281 -
Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique
|
N/A | |
Recruiting |
NCT05142904 -
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
|
Phase 3 | |
Recruiting |
NCT00750711 -
Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters
|
N/A | |
Recruiting |
NCT02793479 -
Radiofrequency Ablation in Patients With Barrett's Esophagus
|
||
Completed |
NCT01091597 -
Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT04417010 -
To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
|
||
Recruiting |
NCT03067493 -
RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial
|
Phase 2 | |
Recruiting |
NCT04471272 -
RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes
|
N/A | |
Recruiting |
NCT04842253 -
HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation.
|
N/A | |
Completed |
NCT04801719 -
Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis
|
N/A |